COVID-19 and its association with abnormal echocardiogram parameters [COVID-19]
Research type
Research Study
Full title
COVID-19 and its association with abnormal echocardiographic parameters – a DGH Experience
IRAS ID
286146
Contact name
Aswin Babu
Contact email
Sponsor organisation
Homerton University Hospital NHS Foundation Trust
Duration of Study in the UK
5 years, 0 months, 1 days
Research summary
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), otherwise known as the coronavirus pandemic (COVID-19) presents one of the greatest medical challenges of our generation. Whilst it commonly affects the respiratory system and causes a viral pneumonia, it has major consequences on the cardiovascular system (the heart). The mechanisms by which COVID-19 affects the heart could be secondary to an increased cardio metabolic demand (heart not receiving and not being able to provide the essential nutrients) from an acute respiratory illness or a primary pathological process (COVID-19 directly affecting heart cells). Observations from Wuhan, the epicenter of the COVID-19 outbreak, have shown a strong association between myocardial injury (heart damage) and adverse outcomes. Currently, there is a lack of literature looking at the association between COVID-19, the degree of myocardial injury and specific echocardiographic parameters (heart scan). Abnormal echocardiographic values have a well established link with unfavorable outcomes. We will undertake a retrospective review of all COVID-19 patients who underwent an echocardiogram between 1st March 2020 and 31st May 2020. We aim to look at the association between COVID-19 positive swab patients and abnormal echocardiographic parameters such as left ventricular dysfunction, right ventricular dysfunction, dilated atria and raised pulmonary artery systolic pressure.
REC name
N/A
REC reference
N/A